Ecuador’s market regulator, the Superintendence for the Control of Market Power (SCPM) has said it detected some irregularities in a recent reverse-auction bidding for supplying medication to the country’s health system. The agency will look into alleged anti-competitive practices, and has said it expects to find evidence of crimes against the State.
“I have in my hands a statement by the Company Superintendence, dealing with their impressions on the Limerickpharma, Ginsberg and Sionpharm case. But let me tell you, this isn’t the only concern” said SCPM’s head, Pedro Páez.
Ecuador’s Public Contract Service (Sercop) has revealed that 416 medications were included in the reverse auction, starting at a cost of $220 million USD. The winners, a joint bid by the three companies above, walked away with the contract for $34.8 million USD. However, all three companies operate out of the same building, raising initial suspicions, as they share an address. Furthermore, Sionpharm and Ginsberg both have the same General Manager registered before the country’s Company registry – a Mr. Marco Serrano. These details were enough to prompt the agency into taking action.
Full Content: El Comercio
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Uruguayan Antitrust Scrutiny Puts Major Meatpacking Deal Between Marfrig and Minerva on Hold
May 19, 2024 by
CPI
Alaska Airlines Seeks Dismissal of Consumer Lawsuit Over $1.9 Billion Hawaiian Airlines Buy
May 19, 2024 by
CPI
Idaho Attorney General Orders Split of Kootenai Health and Syringa Hospital
May 19, 2024 by
CPI
Court Rejects T-Mobile’s Appeal Bid in Antitrust Case Over Sprint Merger
May 19, 2024 by
CPI
Google Requests Judge, Not Jury, to Decide on Antitrust Case
May 19, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI